186 results on '"Kirschner, Michaela B."'
Search Results
2. European Epidemiology of Pleural Mesothelioma—Real-Life Data From a Joint Analysis of the Mesoscape Database of the European Thoracic Oncology Platform and the European Society of Thoracic Surgery Mesothelioma Database
3. Expression of phosphorylated ribosomal protein S6 in mesothelioma patients - correlation with clinico-pathological characteristics and outcome: results from the European Thoracic Oncology Platform (ETOP) Mesoscape project
4. microRNA, epi-microRNA, and cancer
5. List of contributors
6. Correction to: Expression of phosphorylated ribosomal protein S6 in mesothelioma patients - correlation with clinico-pathological characteristics and outcome: results from the European Thoracic Oncology Platform (ETOP) Mesoscape project
7. Deletions of CDKN2A and MTAP Detected by Copy-Number Variation Array Are Associated with Loss of p16 and MTAP Protein in Pleural Mesothelioma
8. Cullin 4B Ubiquitin Ligase Is Important for Cell Survival and Regulates TGF-β1 Expression in Pleural Mesothelioma
9. Dysregulated Expression of the MicroRNA miR-137 and Its Target YBX1 Contribute to the Invasive Characteristics of Malignant Pleural Mesothelioma
10. European Epidemiology of Pleural Mesothelioma—Real-Life Data From a Joint Analysis of the Mesoscape Database of the European Thoracic Oncology Platform and the European Society of Thoracic Surgery Mesothelioma Database
11. Genomic and Transcriptomic Analyses of Malignant Pleural Mesothelioma (MPM) Samples Reveal Crucial Insights for Preclinical Testing
12. Tumor Suppressor microRNAs Contribute to the Regulation of PD-L1 Expression in Malignant Pleural Mesothelioma
13. Chapter 5 - microRNA, epi-microRNA, and cancer
14. Genomic and Transcriptomic Analyses of Malignant Pleural Mesothelioma (MPM) Samples Reveal Crucial Insights for Preclinical Testing
15. Deletions of CDKN2A and MTAP Detected by Copy-Number Variation Array Are Associated with Loss of p16 and MTAP Protein in Pleural Mesothelioma
16. Circulating activin A is a novel prognostic biomarker in malignant pleural mesothelioma – A multi-institutional study
17. A data-driven, knowledge-based approach to biomarker discovery: application to circulating microRNA markers of colorectal cancer prognosis
18. A link between the fibroblast growth factor axis and the miR‐16 family reveals potential new treatment combinations in mesothelioma
19. Expression of phosphorylated ribosomal protein S6 in mesothelioma patients-correlation with clinico-pathological characteristics and outcome:results from the European Thoracic Oncology Platform (ETOP) Mesoscape project
20. Surgical management of lung cancer during the COVID-19 pandemic - a narrative review and single-centre report
21. Surgical management of lung cancer during the COVID-19 pandemic – a narrative review and single-centre report
22. Circulating microRNAs: Association with disease and potential use as biomarkers
23. Primary Lung Cancer Organoids for Personalized Medicine-Are They Ready for Clinical Use?
24. Prognostische Faktoren beim malignen Pleuramesotheliom
25. Primary Lung Cancer Organoids for Personalized Medicine—Are They Ready for Clinical Use?
26. TARGETED DELIVERY OF A SYNTHETIC MICRORNA MIMIC AS AN APPROACH TO CANCER TREATMENT: O3
27. MiR-Score: A novel 6-microRNA signature that predicts survival outcomes in patients with malignant pleural mesothelioma
28. Alterations in BAP1 Are Associated with Cisplatin Resistance through Inhibition of Apoptosis in Malignant Pleural Mesothelioma
29. Tumor Immune Microenvironment and Genetic Alterations in Mesothelioma
30. Tumor Immune Microenvironment and Genetic Alterations in Mesothelioma
31. Importance of Cullin4 Ubiquitin Ligase in Malignant Pleural Mesothelioma
32. Alterations in BAP1 Are Associated with Cisplatin Resistance through Inhibition of Apoptosis in Malignant Pleural Mesothelioma
33. Does miR-1 Play a Role in Malignant Pleural Mesothelioma Development and Progression?
34. ZIC1 Is Silenced and Has Tumor Suppressor Function in Malignant Pleural Mesothelioma
35. O10: TARGETED DELIVERY OF RRM1-SPECIFIC SIRNA LEADS TO TUMOUR GROWTH INHIBITION IN MALIGNANT PLEURAL MESOTHELIOMA
36. Increased Circulating miR-625-3p: A Potential Biomarker for Patients With Malignant Pleural Mesothelioma
37. MicroRNA expression analysis in Chronic Thromboembolic Pulmonary Hypertension using pulmonary endarterectomy derived samples
38. Transcriptional suppression of the miR-15/16 family by c-Myc in malignant pleural mesothelioma
39. When RON MET TAM in Mesothelioma: All Druggable for One, and One Drug for All?
40. Transcriptional suppression of the miR-15/16 family by c-Myc in malignant pleural mesothelioma
41. miR-625-3p and lncRNA GAS5 in Liquid Biopsies for Predicting the Outcome of Malignant Pleural Mesothelioma Patients Treated with Neo-Adjuvant Chemotherapy and Surgery
42. When RON MET TAM in Mesothelioma: All Druggable for One, and One Drug for All?
43. Dysregulated Expression of the MicroRNA miR-137 and Its Target YBX1 Contribute to the Invasive Characteristics of Malignant Pleural Mesothelioma
44. A link between the fibroblast growth factor axis and the miR-16 family reveals potential new treatment combinations in mesothelioma
45. Posttranscriptional regulation controls calretinin expression in malignant pleural mesothelioma
46. FGF2 and EGF induce epithelial–mesenchymal transition in malignant pleural mesothelioma cells via a MAPKinase/MMP1 signal
47. A link between the fibroblast growth factor axis and the miR‐16 family reveals potential new treatment combinations in mesothelioma
48. Posttranscriptional Regulation Controls Calretinin Expression in Malignant Pleural Mesothelioma
49. A proteomics-based approach identifies secreted protein acidic and rich in cysteine as a prognostic biomarker in malignant pleural mesothelioma
50. KCa1.1, a calcium-activated potassium channel subunit alpha 1, is targeted by miR-17-5p and modulates cell migration in malignant pleural mesothelioma
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.